BridgeMD
Comparison of spinal morphine and epidural analgesia for pain control in open colorectal surgery
EU CTIS ID: 2024-520262-58-01
What this study is testing
This trial aims to investigate whether intrathecal morphine is comparable (non-inferior) to thoracic epidural analgesia regarding patient quality of recovery measured with Quality of Recovery-15 swedish version after open colorectal surgery.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Patients aged 18 years or older undergoing resective colorectal surgery with a midline incision in the elective or subacute (priority of surgery within >24 hours after notification) setting.
You likely can't join if
- Contraindications for neuraxial blockade (anticoagulant or antithrombotic therapy in doses according to European guidelines, coagulopathy, volume depletion, sepsis)
- Opioid usage (chronic pain or drug addiction)
- Cognitive dysfunction and/or inability to understand instructions
- Allergy to drugs used
- Pregnancy
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.